Understanding the financial challenges faced by patients with chronic obstructive pulmonary disease (COPD)
Financial Toxicity in Chronic Obstructive Pulmonary Disease
This study is looking at how the high costs of treating COPD, like inhalers and hospital visits, affect patients' health and ability to stick to their treatment plans, and it aims to find ways to help ease these financial struggles.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10998008 on NIH RePORTER |
What this research studies
This research investigates the financial burdens that individuals with chronic obstructive pulmonary disease (COPD) experience due to high treatment costs, including inhaled bronchodilators and hospital visits. It aims to explore how these financial challenges affect patients' health outcomes and medication adherence. By examining the relationship between financial toxicity and health-related quality of life, the study seeks to identify potential interventions to alleviate these burdens. The research will involve collecting data on patients' financial situations and health outcomes to better understand the impact of financial stress on their treatment adherence.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic obstructive pulmonary disease (COPD) who are experiencing financial difficulties related to their treatment.
Not a fit: Patients with COPD who are not facing financial challenges or those who are not actively engaged in treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved support systems for COPD patients, helping them manage treatment costs and enhance their overall health outcomes.
How similar studies have performed: While financial toxicity has been studied in other chronic conditions, this specific focus on COPD is relatively novel and has not been extensively explored.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Mallya, Sonal — Johns Hopkins University
- Study coordinator: Mallya, Sonal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.